SP2456

Star0

DB03957ExperimentalSmall molecule

SP2456: Overview.

Mechanism: Pharmacologically active on Interleukin-2
Curator reviewed
Formula / weight: C₂₅H₃₃Cl₂N₇O₂ · 534.481 g/mol (avg)
Also known as: (2R)-2-Cyclohexyl-2-(diaminomethylideneamino)-N-[2-[4-[3-(2,3-dichlorophenyl)-1H-pyrazol-5-yl]piperidin-1-yl]-2-oxoethyl]acetamide
Code names: SP2456

Resolves to

Compound

ChEMBLCHEMBL106187PubChem447945

Structure

InChIKeySSSXBBASYYVGCI-HSZRJFAPSA-NSMILES[H]N([H])C(=N[C@H](C1CCCCC1)C(=O)N([H])CC(=O)N1CCC(CC1)C1=CC(=NN1[H])C1=C(Cl)C(Cl)=CC=C1)N([H])[H]

Targets

P60568IL2

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with SP2456, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account